{"transactions":[{"id":678478,"issuer":{"id":7608,"kind":"organization","name":"Longeveron Inc.","symbol":"LGVN"},"owners":[{"id":20740,"kind":"person","name":"Ascheim Deborah","position":1,"cik":"0001649531","reported_name":"Ascheim Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-21T22:00:10.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of time-based vesting Restricted Stock Units (RSUs)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs subject to future vesting."}],"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001214659-26-010737","document":"marketforms-73828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649531/000121465926010737/marketforms-73828.xml","form_type":"4"}},{"id":3861614,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":20740,"kind":"person","name":"Ascheim Deborah","position":1,"cik":"0001649531","reported_name":"Ascheim Deborah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-25T21:00:54.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing August 1, 2018, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":1.24,"expiration_date":"2018-07-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-18-039922","document":"tv499203_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418039922/tv499203_4.xml","form_type":"4"}},{"id":4107965,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":20740,"kind":"person","name":"Ascheim Deborah","position":1,"cik":"0001649531","reported_name":"Ascheim Deborah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:01:04.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":43122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"35,000 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. The remaining 8,122 shares will vest 1/12 on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":43122,"derivative":{"exercise_price":1.57,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":43122},"source":{"system":"sec-edgar","filing":"0001144204-18-000854","document":"tv482713_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000854/tv482713_4.xml","form_type":"4"}},{"id":4503376,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":20740,"kind":"person","name":"Ascheim Deborah","position":1,"cik":"0001649531","reported_name":"Ascheim Deborah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T02:40:43.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":2.55,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-17-000699","document":"v456174_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417000699/v456174_4.xml","form_type":"4"}}]}